Table 5.
Domains | Groupa | P-valueb | |||
---|---|---|---|---|---|
| |||||
I | II | III | IV | ||
Abdominal symptoms | 1.01 ± 0.69 | 1.47 ± 0.78 | 1.42 ± 0.79 | 1.98 ± 0.84 | < 0.001 |
Rectal symptoms | 0.74 ± 0.82 | 0.94 ± 0.90 | 0.78 ± 0.80 | 1.24 ± 0.93 | < 0.001 |
Stool symptoms | 1.66 ± 0.99 | 2.02 ± 0.96 | 2.23 ± 0.86 | 2.54 ± 0.93 | < 0.001 |
Total score | 1.22 ± 0.70 | 1.57 ± 0.74 | 1.60 ± 0.67 | 2.01 ± 0.78 | < 0.001 |
Grouping is as follows; group I, patients with no overlap with other disorders; group II, patients overlapped with gastroesophageal reflux disease (GERD); group III, patients overlapped with functional dyspepsia (FD); group IV, patients overlapped with both GERD and FD.
The P-value in each domain was derived from one-way ANOVA test.